#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Malignant melanoma Giant cell tumour of tendon sheath Congenital absence of bile ducts Dermatomyositis Indolent systemic mastocytosis Toxic epidermal necrolysis Neuroendocrine cell hyperplasia of infancy Adenocarcinoma gastric Neuroendocrine tumour of the lung Malignant glioma Ovarian epithelial cancer Acquired haemophilia Ductal adenocarcinoma of pancreas Acquired ATTR amyloidosis Ovarian cancer stage III More trials…

    Learn about Rare Diseases

    Factor VIII deficiency – Treatment Factor VIII deficiency – Life with Disease Wolfram syndrome Congenital nephrogenic diabetes insipidus Familial amyotrophic lateral sclerosis Choroid melanoma Mucopolysaccharidosis – Treatment Congenital nephrogenic diabetes insipidus – Life with Disease Pituitary-dependent Cushing’s syndrome – Trials in Disease Antisynthetase syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    CICLOPIROX Nitric Oxide Marstacimab Co-Trimoxazole Losmapimod GLYCYL-TYROSINE Prax-628 Ropivacaine Citric Acid Sapropterin Dihydrochloride Interferon Gamma Interleukin-2 ADX-038 Aprepitant Prednisolone Sodium Phosphate Crinecerfont Fluorodopa (18F) Gallium (68Ga) Gozetotide Ethanol, Anhydrous Axitinib More therapies…

    Learn about Your Condition

    Hypoaesthesia Idiopathic pulmonary fibrosis Burning mouth syndrome Sepsis Lung transplant rejection Breast cancer stage III Anaemia of chronic disease Abortion threatened Osteotomy Phenylketonuria Post-acute COVID-19 syndrome Hypotonia Chronic hepatic failure Oesophageal adenocarcinoma Dyspepsia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Velocity Clinical Research Luebeck GmbH

Velocity Clinical Research Luebeck GmbH

Demmeringstrasse 47-49, Altlindenau, Luebeck, 04177, Germany

Want to learn more about this study or check if you can participate? Contact us.

  • A Study of Depemokimab Compared to Placebo in Adults with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation

    Recruiting

    3 1 1
    Investigated Drugs:
    • Depemokimab
    • Salbutamol Sulfate
    Belgium Croatia Denmark France Germany Hungary +8

  • Study of budesonide, glycopyrronium and formoterol inhaler to evaluate heart and lung function in patients with chronic obstructive pulmonary disease and hyperinflation

    Recruiting

    3 1 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Glycopyrronium Bromide
    • Budesonide
    • Formoterol Fumarate Dihydrate
    Germany

  • Study of AZD6793 tablets to reduce flare-ups in adults with moderate to very severe chronic obstructive pulmonary disease (COPD)

    Recruiting

    2 1
    Bulgaria Denmark Germany Greece Hungary Italy +2

  • Study of dupilumab injections to reduce airway inflammation in adults aged 40-85 with chronic obstructive pulmonary disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Salbutamol
    • Dupilumab
    Austria Denmark France Germany Hungary Italy +4

  • Study of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Hypertension
    • Type 2 diabetes mellitus
    • Cardiovascular disorder
    Investigated Drugs:
    • Bi 690517
    • Empagliflozin
    Austria Belgium Bulgaria Croatia Czechia Denmark +17

  • Study of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it

    Recruiting

    3 1
    Bulgaria Czechia Denmark France Germany Greece +7

  • Study of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis

    Recruiting

    3 1
    Investigated Diseases:
    • Bronchiectasis
    Investigated Drugs:
    • Bi 1291583
    Austria Belgium Bulgaria Croatia Czechia Denmark +16

  • Evaluating the Effect of Vicadrostat and Empagliflozin Combination Compared to Empagliflozin Alone in Patients with Heart Failure and Reduced Left Ventricular Function

    Recruiting

    3 1 1
    Investigated Diseases:
    • Cardiac failure
    Investigated Drugs:
    • Bi 690517
    • Empagliflozin
    Belgium Bulgaria Czechia Denmark Germany Hungary +6

  • Study of Tezepelumab Compared to Placebo in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

    Recruiting

    3 1 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Tezepelumab
    Czechia Denmark Germany Italy Poland Slovakia +1

  • Study on the Effectiveness of E. coli DSM 17252 for Patients with Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)

    Recruiting

    3 1 1
    Investigated Diseases:
    • Irritable bowel syndrome
    Germany
Previous Page
1 2 3 4 … 7
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!